AL
Lathuiliere, Aurélien
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of neurology |  | 2024 | 40 | 8 | ||
| Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients | Alzheimer's research & therapy | | 2024 | 36 | 5 | ||
| SORL1 is a receptor for tau that promotes tau seeding | Journal of biological chemistry | | 2024 | 14 | 18 | ||
| Maladie d’Alzheimer : ce qui a changé en 2023 | Revue médicale suisse |  | 2024 | 28 | 0 | ||
| Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins | iScience | | 2023 | 41 | 7 | ||
| Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic | Journal of neurology, neurosurgery and psychiatry | | 2023 | 164 | 19 | ||
| Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells | Molecular neurodegeneration | | 2023 | 40 | 5 | ||
| Sustained delivery of low-dose anti-CTLA-4 by genetically engineered encapsulated cells to the tumor microenvironment drives tumor response and prolongs survival in a colorectal cancer model | AACR Annual Meeting 2023 | | 2023 | 19 | 4 | ||
| Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission | European Journal of Nuclear Medicine and Molecular Imaging | | 2023 | 54 | 5 | ||
| From patients to disease: the difficult case of Alzheimer's | The Lancet neurology | | 2022 | 299 | 1 | ||
| Immortalised human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology | Molecular therapy. Methods & clinical development | | 2022 | 91 | 30 | ||
| Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids | Frontiers in neuroscience | | 2021 | 125 | 68 | ||
| Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism | Journal of Biological Chemistry | | 2021 | 153 | 85 | ||
| Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease | Nature medicine | | 2020 | 117 | 1 | ||
| Prise en charge nutritionnelle du sujet âgé en neuro-réadaptation | Revue médicale suisse | | 2019 | 439 | 212 | ||
| How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation? | Nutrients | | 2019 | 129 | 41 | ||
| Un implant bioactif pour prévenir la maladie d'Alzheimer | MS Médecine sciences | | 2017 | 135 | 55 | ||
| Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects | Scientific reports | | 2017 | 111 | 105 | ||
| Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging | Journal of synchrotron radiation | | 2016 | 115 | 31 | ||
| A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies | Brain | | 2016 | 178 | 80 | ||
| Lentiviral Vectors for the Engineering of Implantable Cells Secreting Recombinant Antibodies | Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools |  | 2016 | 126 | 0 | ||
| Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system | International journal of molecular sciences | | 2015 | 150 | 73 | ||
| A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells | Biomaterials | | 2014 | 107 | 1 | ||
| Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation | Biomaterials | | 2014 | 119 | 0 | ||
| Clusterin expression during fetal and postnatal CNS development in mouse | Neuroscience | | 2008 | 637 | 0 | ||
| Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age | Journal of neurochemistry | | 2006 | 121 | 1 |
